I have seen the CR argument raised a million times - dilution etc, etc........
Sure, it slows the SP down whilst the process takes it's course, but that does not stop the company and its progress.
Look at the aspect of having $10,000,000 in the bank to market and develop the product.
There are 125,000,000 families in the USA alone. Take 1000,000 of those families at $75 = $75,000,000 in revenue
Take 1,000,000 families from around the world
- there is over 2 BILLION families in the world. This is the size of the family market available and Family Insites only has to capture a fraction of these numbers to begin generating massive dollars on a low cost APP business model.
This product is not subject to massive development costs and FDA approvals and all the regulatory restrictions that go with some industries and technologies.
I welcome a CR, it will ramp up the speed of making this technology available worldwide.
Then watch the revenue numbers ramp up......and what happens then...yep those institutions with millions will want part of the action.
The narrow minded are locked into the humble beginnings of this company in WA, it does not matter if it is Alice Springs - the formulation is taking place
WGL Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
